In December 2023, regulators in the United States approved the first medicine based on CRISPR gene editing, a treatment for sickle cell disease.
Trending
- America’s Longest Shutdown: 43 Days That Closed the Federal Government
- The First CRISPR Medicine Rewrites the Treatment of Sickle Cell Disease
- Amazon Deforestation Falls to Its Lowest Level Since 1988
- Assisted Dying in England and Wales: A Bill That Passed, Fell, and Failed Again
- Binance Plans Asia Expansion After Record Crypto Heist
- The Atlantic Current That Warms Europe Is Slowing Down
- UN Nations Debate Ban on Autonomous Weapons
- Elephants Remember Friends They Have Not Seen in Years